Surgery Partners outlines 2026 revenue of $3.35B-$3.45B and adjusted EBITDA of at least $530M as portfolio optimization targets mid-2026 announcement (NASDAQ:SGRY)
Surgery PartnersSurgery Partners(US:SGRY) Seeking Alpha·2026-05-06 03:42

新闻内容技术访问问题 - 新闻内容因技术原因无法正常访问，用户浏览器需启用Javascript和cookies，并可能需要禁用广告拦截器以加载页面 [1]

Surgery Partners outlines 2026 revenue of $3.35B-$3.45B and adjusted EBITDA of at least $530M as portfolio optimization targets mid-2026 announcement (NASDAQ:SGRY) - Reportify